NASDAQ:CCCC | Income Statement | C4 Therapeutics, Inc.

Complete source-backed income-statement history.

Available history
2019-09-30 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$6.64M$24.47M$33.06M-$26.42M$2.79M$0.00-$23.64M-$0.18-$0.18130,696,742130,696,742
2026-03-31$6.15M$24.61M$33.94M-$27.79M$2.66M$0.00-$25.13M-$0.20-$0.20126,074,555126,074,555
2025-12-31$11.02M$24.98M$34.16M-$23.15M$2.78M-$20.37M$121,000.00-$20.49M-$0.09-$0.0911,420,75511,420,755
2025-09-30$11.23M$25.99M$45.64M-$34.41M$2.25M-$32.17M$0.00-$32.17M-$0.44-$0.4472,563,31172,563,311
2025-06-30$6.46M$26.2M$34.96M-$28.5M$2.48M-$26.02M$0.00-$26.02M-$0.37-$0.3771,005,74371,005,743
2025-03-31$7.24M$27.07M$36.4M-$29.16M$2.84M-$26.32M$0.00-$26.32M-$0.37-$0.3770,833,04470,833,044
2024-12-31$5.18M$32.51M$42.89M-$37.71M$3.27M-$34.44M$131,000.00-$34.57M-$0.49-$0.49414,055414,055
2024-09-30$15.36M$31.84M$43.61M-$28.24M$3.58M-$24.67M$0.00-$24.67M-$0.35-$0.3569,627,19069,627,190
2024-06-30$12.01M$23.75M$33.45M-$21.44M$3.73M-$17.72M$0.00-$17.72M-$0.26-$0.2668,810,25968,810,259
2024-03-31$3.04M$22.53M$35.26M-$32.22M$3.86M-$28.36M$0.00-$28.36M-$0.41-$0.4168,432,16868,432,168
2023-12-31$3.26M$30.39M$40.69M-$37.43M$2.95M-$34.48M$277,000.00-$34.75M-$0.68-$0.68537,154537,154
2023-09-30$11.07M$28.35M$38.88M-$27.81M$1.77M-$26.03M$1M-$27.04M-$0.55-$0.5549,212,12649,212,126
2023-06-30$2.66M$29.93M$40.23M-$37.57M$1.65M-$35.92M$0.00-$35.92M-$0.73-$0.7349,063,63149,063,631
2023-03-31$3.76M$29.04M$39.99M-$36.23M$1.45M-$34.78M$0.00-$34.78M-$0.71-$0.7149,032,31949,032,319
2022-12-31$2.85M$30.65M$41.15M-$38.29M$1.11M-$37.19M$0.00-$37.19M-$0.76-$0.7634,16234,162
2022-09-30$6.75M$29.66M$39.24M-$32.49M$530,000.00-$31.96M$0.00-$31.96M-$0.65-$0.6548,921,92848,921,928
2022-06-30$13.83M$31.32M$41.22M-$27.38M-$28,000.00-$27.41M-$0.56-$0.5648,823,69848,823,698
2022-03-31$7.65M$26.2M$39.02M-$31.37M-$251,000.00-$31.62M$0.00-$31.62M-$0.65-$0.6548,734,82748,734,827
2021-12-31$20.08M$26.55M$35.33M-$15.26M-$403,000.00-$15.66M$0.00-$15.66M-$0.31-$0.31878,289878,289
2021-09-30$8.5M$24.3M$32.75M-$24.25M-$429,000.00-$24.68M-$24.68M-$0.51-$0.5148,490,53348,490,533
2021-06-30$9.78M$23.29M$31.9M-$22.12M-$464,000.00-$22.58M-$22.58M-$0.51-$0.5143,855,42043,855,420
2021-03-31$20.53M$27.94M-$20.51M-$462,000.00-$20.97M$0.00-$20.97M-$0.4943,084,978
2020-12-31$20.43M$27.17M-$18.9M-$3.02M-$21.92M-$124,000.00-$21.8M$30.939,876,807
2020-09-30$23.94M$26.8M-$18.35M-$3.65M-$22M-$167,000.00-$21.84M-$17.551,540,902
2020-06-30$17.76M$20.53M-$10.86M-$102,000.00-$10.96M-$168,000.00-$10.79M-$9.281,476,378
2020-03-31$16.31M$19.15M-$12.34M$259,000.00-$12.08M-$167,000.00-$11.91M-$9.591,462,759
2019-12-31$16.02M$18.71M-$10.5M$380,000.00-$10.12M-$96,000.00-$10.02M-$8.4417,171
2019-09-30$12.95M$15.37M-$10M$557,000.00-$9.44M$650,000.00-$10.09M-$8.931,376,365

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$35.95M$104.24M$151.17M-$115.22M$10.35M-$104.87M$121,000.00-$104.99M-$1.27-$1.2782,894,45982,894,459
2024-12-31$35.58M$110.64M$155.2M-$119.61M$14.43M-$105.19M$131,000.00-$105.32M-$1.52-$1.5269,372,99369,372,993
2023-12-31$20.76M$117.71M$159.79M-$139.03M$7.82M-$131.21M$1.28M-$132.49M-$2.67-$2.6749,640,50549,640,505
2022-12-31$31.1M$117.84M$160.63M-$129.53M$1.36M-$128.18M$0.00-$128.18M-$2.62-$2.6248,861,66548,861,665
2021-12-31$45.79M$94.67M$127.92M-$82.13M-$1.76M-$83.89M$0.00-$83.89M-$1.82-$1.8246,041,73346,041,733
2020-12-31$78.44M$93.64M-$60.45M-$6.51M-$66.96M-$626,000.00-$66.34M-$5.8311,370,328
2019-12-31$48.06M$56.83M-$35.45M$2.16M-$33.3M$804,000.00-$34.1M-$31.031,371,905